| Eli Lilly And Company | 218K | US$241M | 17.3% |
| Merck & Company, Inc. | 709K | US$84.2M | 6.1% |
| Unitedhealth Group Incorporated | 214K | US$81.5M | 5.9% |
| Thermo Fisher Scientific Inc | 128K | US$63.3M | 4.6% |
| Argenx Se | 59,035 | US$49.4M | 3.6% |
| Vertex Pharmaceuticals Incorporated | 104K | US$46.7M | 3.4% |
| Danaher Corporation | 250K | US$45.6M | 3.3% |
| Intuitive Surgical, Inc. | 101K | US$42.7M | 3.1% |
| Lonza Group Ag | 65,672 | US$41.9M | 3.0% |
| Cvs Health Corporation | 385K | US$35M | 2.5% |
| Insmed Incorporated | 296K | US$31.7M | 2.3% |
| Roivant Sciences Ltd. | 1.02M | US$30.7M | 2.2% |
| Stryker Corporation | 98,162 | US$29.9M | 2.2% |
| Sionna Therapeutics, Inc. | 651K | US$27.9M | 2.0% |
| Beone Medicines Ltd. Class A | 87,672 | US$25.2M | 1.8% |
| Vaxcyte, Inc. | 479K | US$24.6M | 1.8% |
| Align Technology, Inc. | 139K | US$24.3M | 1.8% |
| Agilent Technologies, Inc. | 177K | US$24M | 1.7% |
| Palvella Therapeutics, Inc. | 183K | US$21.7M | 1.6% |
| Apogee Therapeutics, Inc. | 240K | US$19.7M | 1.4% |
| Cabaletta Bio, Inc. | 4.96M | US$18.8M | 1.4% |
| Newamsterdam Pharma Company N.v. | 534K | US$18M | 1.3% |
| Dianthus Therapeutics, Inc. | 191K | US$17.7M | 1.3% |
| Kymera Therapeutics, Inc. | 216K | US$17.6M | 1.3% |
| Scholar Rock Holding Corporation | 352K | US$17.4M | 1.3% |
| Celcuity Inc. | 111K | US$14.8M | 1.1% |
| Revolution Medicines, Inc. | 93,878 | US$14.8M | 1.1% |
| Astrazeneca Plc | 79,048 | US$14.7M | 1.1% |
| Mineralys Therapeutics, Inc. | 460K | US$14.5M | 1.0% |
| Teva Pharmaceutical Industries Limited | 395K | US$13.9M | 1.0% |
| Xenon Pharmaceuticals Inc. | 253K | US$13.8M | 1.00% |
| Disc Medicine, Inc. | 198K | US$13.8M | 0.99% |
| Protagonist Therapeutics, Inc. | 135K | US$13.5M | 0.97% |
| Bayer Ag | 306K | US$13M | 0.94% |
| Veradermics, Incorporated | 128K | US$12.9M | 0.93% |
| Tandem Diabetes Care, Inc. | 680K | US$11.7M | 0.84% |
| Erasca, Inc. | 878K | US$11.3M | 0.81% |
| Crinetics Pharmaceuticals, Inc. | 277K | US$9.86M | 0.71% |
| Tarsus Pharmaceuticals, Inc. | 163K | US$9.66M | 0.70% |
| Immunovant, Inc. | 278K | US$9.25M | 0.67% |
| Avalyn Pharma Inc. | 318K | US$9.17M | 0.66% |
| Olema Pharmaceuticals, Inc. | 663K | US$8.74M | 0.63% |
| Elanco Animal Health Incorporated | 359K | US$8.56M | 0.62% |
| Arcutis Biotherapeutics, Inc. | 391K | US$8.4M | 0.60% |
| Seaport Therapeutics, Inc. | 439K | US$7.98M | 0.57% |
| Abivax Sa | 56,533 | US$7.5M | 0.54% |
| Uniqure N.v. | 250K | US$7.14M | 0.51% |
| Lb Pharmaceuticals Inc | 231K | US$6.47M | 0.47% |
| Tyra Biosciences, Inc. | 183K | US$6.11M | 0.44% |
| Enliven Therapeutics, Inc. | 126K | US$4.97M | 0.36% |
| Spyre Therapeutics, Inc. | 64,063 | US$4.71M | 0.34% |
| Oruka Therapeutics, Inc. | 76,396 | US$4.47M | 0.32% |
| Regeneron Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ucb S.a. | 0 | US$0 | 0.00% |
| Edwards Lifesciences Corporation | 0 | US$0 | 0.00% |
| Gilead Sciences, Inc. | 0 | US$0 | 0.00% |
| Viridian Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |